欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	CZ/H/1000/002
药品名称	Kartesada
活性成分	pregabalin 150.0 mg
剂型	Capsule, hard
上市许可持有人	Previous MRP: PT/H/1424 Egis Pharmaceuticals PLC Keresztúri út. 30-38 1106 Budapest The Czech Republic
参考成员国 - 产品名称	Czechia (CZ) KARTESADA
互认成员国 - 产品名称	Slovakia (SK) Kartesada 150 mg tvrdé kapsuly
许可日期	2017/04/28
最近更新日期	2024/07/17
药物ATC编码	N03AX16 pregabalin
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final SPC \| common_spc_kartesada_var011_cleanDate of last change:2022/06/02 Final PL \| common_pl_kartesada_var011_cleanDate of last change:2022/06/02 PAR \| 1424_Kartesada_Summary_PAR&Scientific_PAR_Final__23JUN2017Date of last change:2019/11/19 Final Product Information \| common-impack-75mgDate of last change:2017/07/04 Final Product Information \| common-outer-150mgDate of last change:2017/07/04 Final Product Information \| common-outer-75mgDate of last change:2017/07/04 Final Product Information \| common-impack-150mgDate of last change:2017/07/04 Final Product Information \| common-impack-300mgDate of last change:2017/07/04 Final Product Information \| common-spc-pregabalin_update20170207Date of last change:2017/07/04 Final Product Information \| common-outer-300mgDate of last change:2017/07/04 Final Product Information \| common-pl-pregabalinDate of last change:2017/07/04
市场状态	Positive